The induction of p21 in TGF-β-treated colon cancer cells correlated with reduced cyclin E-associated kinase activity in vitro and reduced pRb phosphorylation in vivo, suggesting that p21 sensitizes cancer cells to TGF-β-induced cell cycle arrest [98]. Here, TGFB1 is linked to malignant colon neoplasm.